MedPath
HSA Approval

MOMETASONE SANDOZ NASAL SPRAY 0.05%

SIN15328P

MOMETASONE SANDOZ NASAL SPRAY 0.05%

MOMETASONE SANDOZ NASAL SPRAY 0.05%

September 7, 2017

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Therapeutic

Prescription Only

Formulation Information

SPRAY, SUSPENSION

NASAL

Medical Information

R01AD09

mometasone

Manufacturer Information

SANDOZ SINGAPORE PTE. LTD.

Lek Pharmaceuticals d.d.

Active Ingredients

Mometasone furoate monohydrate 51.731ug eqv to Mometasone furoate

50ug per actuation

Mometasone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MOMETASONE SANDOZ NASAL SPRAY 0.05% - HSA Approval | MedPath